Drs. Neal Kassell, Jeff Elias and Jason Sheehan are leading the development of high-intensity focused ultrasound technology, which has exciting potential for drug delivery and to treat tumors, stroke, and movement disorders non-invasively. Dr. Elias's clinical trial to treats patients with Essential Tremor is believed to have been the first intracranial therapeutic application of the technology in the world, and its favorable results have been published in the New England Journal of Medicine. Dr. Elias is currently enrolling patients in a trial to treat tremor-dominant Parkinson's and multiple other focused ultrasound trials are enrolling or in development.
Dr. Edward Oldfield is pursuing laboratory and clinical research to understand the basis of the pathogenesis of central nervous system tumors, including pituitary tumors and syringomyelia. He is also researching drug delivery approaches that can be used to treat brain tumors and other neurological disorders, including neuro-degenerative disorders, such as Parkinson's disease. Neurologist Dr. Deric Park collaborates with Dr. Oldfield, and pursues his own research interests, including research on the developmental basis for the origin and progression of brain tumors.
The neuro-oncology and spine areas are involved in most all major national clinical trials. Our clinical trials page has links to information about clinical trials led by our doctors and doctors across UVA.
We are also active in other areas of research including Epilepsy, Parkinson's Disease, and more.
Donate to Our Research
We've had many grateful patients and philanthropists help support our Neurosurgery and Neuroscience research at UVA. Without them, we would not have accomplished so much.
As an example, a patient came to UVa's top ranked Neuroendocrine team for surgery to remove a pituitary tumor. He was so impressed with the care he received that he decided to help advance UVa's research into finding better treatments for the disease. His gifts of more than $200,000 have helped our neurosurgeons and endocrinologists devise a way to genetically map a tumor's DNA, giving vital clues to why pituitary tumors form, and to help discover and clone a receptor that may be a target for new therapies to stop tumor growth.
"The pace of our research, and the milestones we've reached, would not be possible without the help of such donors," says leading endocrinologist Michael Thorner. "Private support seeds promising research and allows investigators to explore novel ideas. With help from donors, we are developing a strategy for defeating pituitary tumors. We are working toward a cure."
If you'd like to donate online, a form to do so is at:
If you'd like to discuss with any of our faculty members, find their contact info at Neurosurgery Faculty Contact Page
You might also contact Jas Heim, the Neurosciences specialist within UVA Health System's Development Office, at 434-982-0313 or by email .